ArticleJournal of inflammation research2026
Elevated Systemic Immune-Inflammation Index is Associated with Gestational Diabetes Mellitus: A Multicenter Retrospective Studies.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Higher neutrophil count, higher lymphocyte-to-monocyte ratio, and lower platelet-to-lymphocyte ratio are independently associated with postpartum depression symptoms in twin pregnancies.Frontiers in immunology · 2026Article
- Artificial intelligence for early prediction of gestational diabetes mellitus and preeclampsia: a systematic review of machine learning models and clinical decision support systems.Frontiers in artificial intelligence · 2026Review
- Blood Count-Derived Inflammatory Indices at Two Timepoints in Insulin-Treated Gestational Diabetes: A Retrospective Cohort Study.International journal of women's health · 2026Article
- Multi-Omics Identification of Key Immune Molecules in Gestational Diabetes Mellitus: FKBP5 and HLA-DQA1 as Candidate Biomarkers.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The systemic immune-inflammation index (SII), an integrative biomarker reflecting inflammatory and immune status, has been implicated in metabolic disorders. However, its association with gestational diabetes mellitus (GDM) remains unclear. This study aimed to investigate whether elevated SII is associated with an increased risk of GDM. Objective: We aimed to clarify whether systemic SII is related to the occurrence of GDM and the relationship between changes in SII and adverse pregnancy outcomes associated with GDM. Methods: This study analyzed 47,480 singleton pregnancies between 2018 and 2024, including 6599 GDM cases and 40,881 controls. SII was calculated before 24 weeks of gestation, and participants were categorized by SII quartiles. Multivariable logistic regression was used to assess associations between SII and GDM (primary outcome), insulin-requiring GDM (A2), preeclampsia, and large-for-gestational-age infants. In addition, interaction tests and smooth curve fitting methods were adopted to explore the relationship between SII and gestational diabetes mellitus (GDM) and related adverse pregnancy outcomes. Results: After adjustment, higher SII quartiles showed a dose-dependent increase in GDM risk: Q2 (aOR = 1.19, 95% CI: 1.08-1.30), Q3 (aOR = 1.26, 1.15-1.38), Q4 (aOR = 1.56, 1.43-1.71; P < 0.0001). Stronger associations were observed for GDM A2 and GDM with preeclampsia. The association with LGA was weaker and only significant in Q3. Subgroup analyses revealed consistent associations across age and BMI, though the effect was marginally stronger in multiparous women (interaction P=0.0213<0.05). No significant interactions were found for BMI or age. Conclusion: Elevated SII in early pregnancy is independently associated with an increased risk of GDM, supporting its potential utility as an early predictive marker for GDM screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.